


Autologous Cell Therapy
Over the years Autologous Cell Therapy (ACT) has become a rapidly evolving field. The use of ACT has been reported from as early as 1985. The scope for ACT is vast and has immense potential for rejuvenation. Autologous material is utilized as both a stand-alone treatment or in composite with other materials.
Cosmetic enhancement or corrective surgeries are on the increase, the search for a more clinically efficacious and longer lasting autologous filler is over. Since as early as 1899, the use of materials for superficial soft tissue wrinkles and contour imperfections has been sought after and with millions of people every year undergoing cosmetic surgery, the market for treatments that have an increased longevity or improve healing are highly sought after.
Plasma Filler and i-PRF can be combined to create an advanced bi-phasic treatment protocol or i-PRF can be offered in conjunction with microneedling or meso injection as a simple monotherapy treatment for skin and hair restoration.

Cell Concentration

GROWTH FACTORS
7 Fundamental growth factors are released by platelets:
EGF, PDGF, VGF, IGF, KGF, TGF-B, FGF

PLATELETS
Platelets only release growth factors once activated.
Anticoagulant inhibits the activation of platelets

LEUKOCYTES
Leukocytes have a strong influence on the release of growth factors.
Leukocyte rich plasma releases larger amounts of molecules;
Superior for wound healing – scars and skin needling

CELL RICH
i-PRF Smart Cell system contains activated platelets, leukocytes (WBC) & mesenchymal stem cells

MEDICAL DEVICE
The i-PRF Smart Cell system uses biocompatible medical device (class IIb) tubes specifically designed for autologous therapy

FIBRIN MESH
Fibrinogen is the key. The fibrin matrix traps the platelets, growth factors and bioactive molecules

100% NATURAL
i-PRF Smart Cell system is 100% natural, completely free of chemicals, additives or clotting factors

i-PRF does not use anti-coagulant. Anticoagulants inhibit tissue regeneration and platelet activation. Some anti-coagulants may instigate platelet aggregation, this will result in a lower platelet count during harvest, especially in traditional PRP following a hard spin!